Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

Stop TB Partnership launches 2-month online consultation for the Global Plan to Stop TB 2016-2020

logo5

The Stop TB Partnership is today launching the online consultation into the first public draft of the Global Plan to Stop TB 2016-2020. The consultation process is open to everyone and, will run from 10 June to 10 August 2015.

1 Jun 2015
by Working Group

Posted in Front Lines of TB R&D, TB Drug Development

JID Journal Supplement: Tuberculosis Drug Development

12.cover

A supplement dedicated to TB drug development appears in the Journal of Infectious Diseases Volume 211, June 15, 2015. Topics include nonclinical models of TB drug development, PKPD and dose response, drug metabolism and interactions, and special populations.

Kick TB Campaign Expands to Brazil

soccerballFront-300x290

The Kick TB Campaign is a unique project that uses the World’s most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis. First inaugurated in South Africa during the 2010 World Cup, Kick TB has expanded to Brazil, the host country of the 2014 World Cup.

26 Nov 2013

EMA Reverses Opinion on Delamanid for MDR-TB

otsuka

A European Union panel has recommended regulatory approval of a tuberculosis drug that would become only the second major new antibiotic against the deadly disease in more than 40 years.

25 Oct 2013

WHO Global TB Report 2013: Slow decline in Disease Burden, New Tools Needed to Reach Goals

GTBR13_cover M inhouse

This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress made to date. Additional links to news coverage of the report are included

10 Jul 2013
by Working Group

Posted in Faces of TB, TB Drug Development, TB News

How to Combat Tuberculosis: NPR Highlights

npr

Yesterday, the US National Public Radio posted online two insightful pieces on tuberculosis: 1) What It Takes To Cure Drug-Resistant Tuberculosis 2) Treating The ‘Body And Soul’ In A Russian TB Prison

1 Jul 2013
by Working Group

Posted in Action, TB Drug Development, TB News

TAG Releases 2013 Pipeline Report

Click here to access full report

HIV i-Base and Treatment Action Group (TAG) called on global and national leaders, research sponsors, and regulatory authorities to work together to make the best HIV, HCV, and TB drugs, diagnostics, and vaccines accessible as fast as possible, according to a report released today at the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.

24 Jun 2013
by Working Group

Posted in Announcements, Early Drug Development, Events

“Targets for Tomorrow” Workshop at GRC in Italy July 2013

tb-review-4.10-lipsitch-feature

We invite you to join us for the “Targets for Tomorrow” satellite workshop hosted by the WGND Biology/Targets Subgroup on Monday, July 22, 2013 from 2 p.m. to 4:30 p.m. at the Renaissance Tuscany Il Ciocco Resort, Lucca (Barga), Italy.

13 Jun 2013

WHO Issues Interim Guidance on the Use of Bedaquiline to Treat

who-logo

The World Health Organization (WHO) has issued interim guidance on the use of bedaquiline, a new tuberculosis drug, for the treatment of multidrug-resistant tuberculosis (MDR-TB).

UPDATE Exposed: Aeras’ Film Series on Tuberculosis

exposed

Release of Chapter 1 of EXPOSED occured the week of May 20. EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals – an MDR-TB survivor, a TB doctor, a clinical trial volunteer, and a TB vaccine researcher – bringing viewers to the forefront of the race against tuberculosis. Click article to view the trailer and Chapter 1 “The Global Epidemic”.